Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev LtdfiledCriticalGlaxosmithkline Ip Dev Ltd
Priority claimed from PCT/US2013/059619external-prioritypatent/WO2014043446A1/fr
Publication of MA37921A1publicationCriticalpatent/MA37921A1/fr
Publication of MA37921B1publicationCriticalpatent/MA37921B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne des composés ayant la formule (i), dans laquelle x est tel que défini dans la description; et des procédés de fabrication et d'utilisation de ces composés.
MA37921A2012-09-132013-09-13Promédicaments d'un inhibiteur de kinase amino-quinazoline
MA37921B1
(fr)